544 related articles for article (PubMed ID: 29852399)
1. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
[TBL] [Abstract][Full Text] [Related]
2. Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green.
Verjans JW; Osborn EA; Ughi GJ; Calfon Press MA; Hamidi E; Antoniadis AP; Papafaklis MI; Conrad MF; Libby P; Stone PH; Cambria RP; Tearney GJ; Jaffer FA
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1087-1095. PubMed ID: 27544892
[TBL] [Abstract][Full Text] [Related]
3. Activatable Fluorescence Imaging of Macrophages in Cerebral Aneurysms Using Iron Oxide Nanoparticles Conjugated With Indocyanine Green.
Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
Front Neurosci; 2020; 14():370. PubMed ID: 32390794
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-targeted, enzyme-triggered fluorescence switch-on system for detection of embolism-vulnerable atherosclerotic plaques.
Narita Y; Shimizu K; Ikemoto K; Uchino R; Kosugi M; Maess MB; Magata Y; Oku N; Ogawa M
J Control Release; 2019 May; 302():105-115. PubMed ID: 30936020
[TBL] [Abstract][Full Text] [Related]
5. Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels.
Lee S; Lee MW; Cho HS; Song JW; Nam HS; Oh DJ; Park K; Oh WY; Yoo H; Kim JW
Circ Cardiovasc Interv; 2014 Aug; 7(4):560-9. PubMed ID: 25074255
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
7. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.
Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ
J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478
[TBL] [Abstract][Full Text] [Related]
8. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
Kim M; Sahu A; Kim GB; Nam GH; Um W; Shin SJ; Jeong YY; Kim IS; Kim K; Kwon IC; Tae G
J Control Release; 2018 Jan; 269():337-346. PubMed ID: 29175140
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques.
Vinegoni C; Botnaru I; Aikawa E; Calfon MA; Iwamoto Y; Folco EJ; Ntziachristos V; Weissleder R; Libby P; Jaffer FA
Sci Transl Med; 2011 May; 3(84):84ra45. PubMed ID: 21613624
[TBL] [Abstract][Full Text] [Related]
11. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.
Bhavane R; Badea C; Ghaghada KB; Clark D; Vela D; Moturu A; Annapragada A; Johnson GA; Willerson JT; Annapragada A
Circ Cardiovasc Imaging; 2013 Mar; 6(2):285-94. PubMed ID: 23349231
[TBL] [Abstract][Full Text] [Related]
12. Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography-Based Imaging-Brief Report.
Li W; Luehmann HP; Hsiao HM; Tanaka S; Higashikubo R; Gauthier JM; Sultan D; Lavine KJ; Brody SL; Gelman AE; Gropler RJ; Liu Y; Kreisel D
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1030-1036. PubMed ID: 29567678
[TBL] [Abstract][Full Text] [Related]
13. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
14. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery.
Kim S; Lee MW; Kim TS; Song JW; Nam HS; Cho HS; Jang SJ; Ryu J; Oh DJ; Gweon DG; Park SH; Park K; Oh WY; Yoo H; Kim JW
Eur Heart J; 2016 Oct; 37(37):2833-2844. PubMed ID: 26787442
[TBL] [Abstract][Full Text] [Related]
16. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
18. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
[TBL] [Abstract][Full Text] [Related]
19. Macrophage targeted theranostic strategy for accurate detection and rapid stabilization of the inflamed high-risk plaque.
Song JW; Nam HS; Ahn JW; Park HS; Kang DO; Kim HJ; Kim YH; Han J; Choi JY; Lee SY; Kim S; Oh WY; Yoo H; Park K; Kim JW
Theranostics; 2021; 11(18):8874-8893. PubMed ID: 34522216
[No Abstract] [Full Text] [Related]
20. A Novel iRFP-Incorporated in vivo Murine Atherosclerosis Imaging System.
Kulathunga K; Hamada M; Hiraishi Y; Otake M; Tran MTN; Cheng O; Tanaka J; Sakasai T; Sakaguchi S; Sugiyama Y; Fleischmann BK; Takahashi S; Miwa Y
Sci Rep; 2018 Sep; 8(1):14515. PubMed ID: 30266983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
